Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02493530
Title TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications

polycythemia vera

myelofibrosis

myelodysplastic/myeloproliferative neoplasm

Therapies

Ruxolitinib + Umbralisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.